February 4, 2020
Japanese generic major Towa Pharmaceutical said on February 3 that it completed all necessary procedures for the buyout of Spanish generic company Pensa Investments as of January 31, making it a wholly owned subsidiary. The acquisition costs totaled €329 million...read more